Target intelligence / Profile preview

BORCS7-ASMT readthrough (BORCS7-ASMT)

Target: BORCS7-ASMT
Molecular classification: long non-coding RNA (lncRNA), readthrough transcript

Overview

BORCS7-ASMT readthrough is a naturally occurring long non-coding RNA (lncRNA) transcript that spans the neighboring genes BORCS7 (C10orf32) and AS3MT on chromosome 10. It is considered a candidate for nonsense-mediated mRNA decay and is not believed to encode a protein. As such, it does not function as a protein, enzyme, transporter, or therapeutic target, and currently there is no evidence linking it to biological functions, disease involvement, drug interactions, or biomarker utility.

Other names: C10orf32-ASMT readthroughC10ORF32-ASMTGC10P102856GC10P102858GC10P104149GC10P104951GC10P107059

Beyond the preview

Go deeper on BORCS7-ASMT readthrough (BORCS7-ASMT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BORCS7-ASMT readthrough (BORCS7-ASMT).

Explore the full profile